← Leaderboards
David R Friend
Magee-Women'S Res Inst And Foundation
$4,956,000
Attributed
$4,956,000
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,956,000 · 5
By mechanism
R44$2,307,527 · 1
U19$1,406,362 · 1
R01$607,803 · 1
R41$384,972 · 1
R43$249,336 · 1
Top collaborators
No co-investigators on record.
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Janet M Catov$6,992,061
- Catherine Chappell$994,933
Others in their field
Top investigators on “Collaborations”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$557,285,233
- David Heimbrook · Leidos Biomedical Research, Inc.$519,426,565
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$479,076,140
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Albert Lazzarini · California Institute Of Technology$382,990,355
Research focus
CollaborationsPharmaceutical PreparationsVaginal GelEnsureWomanAnimalsDosePregnancyEvaluationBaseTenofovirVaginaResearch Clinical TestingProtocols DocumentationSafetyIn VitroBiological SciencesIn VivoDevicesPreventionClinicPreventTechnologyAffect
Grant awards (11)
A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women$1,016,258
R44 · FY2025 · HD · contact PI
A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women$991,573
R44 · FY2024 · HD · contact PI
Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth$384,972
R41 · FY2023 · HD · contact PI
Defining end-user preferences among US women to optimize the design of a long-acting injectable hormonal contraceptive$249,336
R43 · FY2022 · HD · contact PI
A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women$299,696
R44 · FY2020 · HD · contact PI
Novel long-acting microbicide and contraceptive intrauterine system$607,803
R01 · FY2014 · AI · contact PI
Pharmaceutical and Regulatory Core$130,215
U19 · FY2014 · AI · contact PI
Pharmaceutical and Regulatory Core$375,668
U19 · FY2013 · AI · contact PI
Pharmaceutical and Regulatory Core$323,809
U19 · FY2012 · AI · contact PI
Pharmaceutical and Regulatory Core$219,874
U19 · FY2011 · AI · contact PI
Pharmaceutical and Regulatory Core$356,796
U19 · FY2010 · AI · contact PI